| Autor: |
Lebedenko AA; Kafedra detskikh bolezneĭ #2 Rostovskogo gosudarstvennogo meditsinskogo universiteta, Rostov-na-Donu., Mal'tsev SV |
| Jazyk: |
ruština |
| Zdroj: |
Vestnik otorinolaringologii [Vestn Otorinolaringol] 2011 (4), pp. 66-7. |
| Abstrakt: |
The objective of the present study was to estimate the efficacy and safety of combination of anti-inflammatory treatment of bronchial asthma (BA) and therapy with erespal. A total of 57 children aged from 6 to 14 years were available for the observation. They presented with mild intermittent (n=27), mild persisting (n=20), and moderately severe (n=10) forms of the disease. The traditional treatment of all the patients was supplemented by daily intake of erespal syrup at a dose of 4 mg/kg b.w. from the first day after admission to the hospital. It is concluded based on the results of the study that the use of erespal reduces the duration of the disease and the time of recovery of bronchial patency; also, it accelerates the process of arterial blood saturation with oxygen. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
